Akebia Therapeutics (AKBA) Assets (2013 - 2026)
Akebia Therapeutics' Assets came in at $349.66 million for Q2 2026, up 1.2% from $345.6 million a year earlier but down 3.5% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Akebia Therapeutics' Assets was $376.57 million, up 70.6% from FY2024.
- Assets carries a five-year compound annual growth rate of -10.2% (FY2020 to FY2025).
- Going back by year, Assets was $220.67 million in FY2024 (-8.7%), $241.7 million in FY2023 (-32.1%), $356.05 million in FY2022 (-32.7%) and $529.35 million in FY2021 (-17.8%).
- The five-year range for quarterly Assets is $207.14 million (Q3 2024) to $602.27 million (Q3 2021).
- Year-over-year, Assets has increased for six consecutive quarters, with growth averaging 29.8% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2025 (growth of 75.8%), and the weakest in Q2 2023 (a decline of 52.1%).
- Business Quant data shows AKBA's Assets at $362.52 million (Q1 2026), $376.57 million (Q4 2025) and $364.15 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn | 349.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 349.66 Mn |
| Mar 31, 2026 | 362.52 Mn |
| Dec 31, 2025 | 376.57 Mn |
| Sep 30, 2025 | 364.15 Mn |
| Jun 30, 2025 | 345.60 Mn |
| Mar 31, 2025 | 310.19 Mn |
| Dec 31, 2024 | 220.67 Mn |
| Sep 30, 2024 | 207.14 Mn |
| Jun 30, 2024 | 220.20 Mn |
| Mar 31, 2024 | 225.48 Mn |
| Dec 31, 2023 | 241.70 Mn |
| Sep 30, 2023 | 235.00 Mn |
| Jun 30, 2023 | 253.71 Mn |
| Mar 31, 2023 | 280.93 Mn |
| Dec 31, 2022 | 356.05 Mn |
| Sep 30, 2022 | 444.25 Mn |
| Jun 30, 2022 | 529.88 Mn |
| Mar 31, 2022 | 541.80 Mn |
| Dec 31, 2021 | 529.35 Mn |
| Sep 30, 2021 | 602.27 Mn |
API Access
Akebia Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();